Cultivar Variants · Mushroom/Fungi
Reishi Black Antler (Ganoderma lucidum) (Ganoderma lucidum)
Preliminary EvidenceCompound
Hermetica Superfood Encyclopedia
Reishi Black Antler (Ganoderma lucidum) is a medicinal fungus whose primary bioactive compounds — triterpenoids (ganoderic acids) and beta-glucan polysaccharides — modulate immune signaling and reduce oxidative stress. These compounds interact with immune receptors and hepatic enzymes to support liver function, antioxidant defenses, and immune regulation.
Reishi Black Antler is a distinctive cultivar variant of Ganoderma lucidum, characterized by its antler-shaped, dark fruiting bodies, native to East Asian hardwood forests. This medicinal mushroom is typically extracted using hot water or ethanol methods to isolate bioactive polysaccharides (beta-glucans) and triterpenoids (ganoderic acids).
Clinical evidence includes a double-blind RCT (n=84) showing no benefits for type 2 diabetes or metabolic syndrome over 16 weeks (PMID 27592562), and a 6-month RCT (n=42) demonstrating antioxidant and hepatoprotective effects with 225 mg/day enriched extract (PMID 30078193). A meta-analysis of multiple RCTs concluded no cardiovascular benefits with increased mild adverse events (PMID 25686270).
Clinically studied dose: 225 mg/day of triterpenoids- and polysaccharides-enriched extract taken as capsules post-meal for 6 months. Variable doses reported across studies without consistent standardization. Consult a healthcare provider before starting any new supplement.
Reishi Black Antler (Ganoderma lucidum) is a low-calorie fungal material with a complex bioactive composition. Macronutrients per 100g dry weight: protein 10–40g (varies by strain and substrate; contains all essential amino acids, notably glutamic acid, aspartic acid, and lysine), carbohydrates 55–75g (predominantly polysaccharides and fiber), fat 1–3g (including oleic acid, stearic acid, and palmitic acid). Dietary fiber: 50–60g/100g dry weight, primarily as beta-glucans (β-1,3/1,6-glucan) at approximately 10–50mg/g dry extract — the primary immunomodulatory fraction. Key bioactive compounds: Triterpenoids (ganoderic acids A, B, C, D, G, H, I, J — predominantly in antler/young fruiting body stage) at 1–6% dry weight, with ganoderic acid A most studied at concentrations of ~0.1–2mg/g; these exhibit higher concentration in the 'black antler' (young primordia) stage compared to mature caps. Polysaccharides (GLP, GL-PS): 10–50% of extract dry weight depending on extraction method — water extraction favors polysaccharides, ethanol extraction favors triterpenoids. Adenosine: ~0.1–0.5mg/g (platelet aggregation inhibition activity). Ergosterol (provitamin D2 precursor): ~0.3–1.2mg/g dry weight; converts to vitamin D2 upon UV exposure. Minerals per 100g dry weight: potassium ~3,500–8,000mg, phosphorus ~1,800–3,200mg, magnesium ~200–500mg, calcium ~200–600mg, zinc ~5–10mg, iron ~3–8mg, germanium (organic) ~800–2,000ppm (notably high versus other mushrooms, contributing to antioxidant activity). Vitamins: B3 (niacin) ~40–80mg/100g, B2 (riboflavin) ~3–7mg/100g, B1 (thiamine) ~1–3mg/100g; vitamin C trace levels only. Bioavailability notes: Triterpenoids have moderate oral bioavailability; lipid co-administration may enhance absorption. Beta-glucans are poorly absorbed intact but exert activity via gut-associated lymphoid tissue (GALT) pattern recognition receptors (Dectin-1, TLR-2); hot water or dual extraction significantly increases polysaccharide and triterpenoid bioavailability versus raw powder. The 'black antler' morphological stage is specifically enriched in triterpenoids and adenosine relative to mature Reishi caps, with some reports indicating 20–30% higher ganoderic acid concentration.
Ganoderic acids in Ganoderma lucidum inhibit NF-κB signaling and suppress pro-inflammatory cytokines (TNF-α, IL-6), while beta-glucan polysaccharides activate pattern recognition receptors (Dectin-1, TLR2/4) on macrophages and natural killer cells to enhance innate immunity. Triterpene compounds also inhibit HMG-CoA reductase activity and modulate hepatic lipid metabolism enzymes, contributing to observed reductions in hepatic fat accumulation. Additionally, ganoderic acids upregulate Nrf2-mediated antioxidant pathways, increasing endogenous superoxide dismutase (SOD) and glutathione peroxidase activity.
A randomized, placebo-controlled trial (PMID 30078193) in healthy and affected adults demonstrated that Ganoderma lucidum supplementation reduced oxidative stress biomarkers and improved antioxidant enzyme status, while ultrasonographic normalization of mild fatty liver and gallbladder polyps was observed in a subset of participants with baseline abnormalities. Immune modulation evidence includes enhanced natural killer cell activity and improved cytokine profiles in multiple small-to-moderate trials, though most studies involve fewer than 100 participants and short durations of 4–12 weeks. Overall evidence is rated moderate, with larger, longer-term RCTs needed to confirm dose-response relationships and long-term efficacy. Current data support plausible mechanistic benefits but do not yet meet the threshold for definitive clinical recommendations.
Reishi is generally well tolerated at typical supplemental doses of 1.5–9 g/day of dried extract, with mild side effects including gastrointestinal discomfort, dry mouth, and dizziness reported in some users during the first weeks of use. Because ganoderic acids have demonstrated antiplatelet and anticoagulant properties in vitro, concurrent use with blood-thinning medications such as warfarin, aspirin, or clopidogrel warrants caution and medical supervision. Reishi may potentiate the hypoglycemic effects of antidiabetic drugs, requiring monitoring of blood glucose levels. Safety data in pregnant or breastfeeding individuals are insufficient, and use is not recommended in these populations without physician guidance.
Functional mushroom gummies — Lion's Mane, Reishi, Cordyceps, Chaga & Maitake.
